The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The market for injectable weight loss medications has experienced rapid growth. Goldman Sachs Research predicts the global ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...